[EN] STRONTIUM-CONTAINING COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIC BONE CONDITIONS<br/>[FR] COMPOSES A BASE DE STRONTIUM DESTINES A ETRE UTILISES DANS LA PREVENTION OU LE TRAITEMENT DE CONDITIONS D'OS NECROTIQUES
申请人:OSTEOLOGIX AS
公开号:WO2005082385A1
公开(公告)日:2005-09-09
A method for the treatment and/or prophylaxis of an ostenonecrotic bone disease in a mammal in need thereof, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis, glucocorticoid induced bone ischemia/osteonecrosis, Legg-Calve-Perthes disease and femoral head necrosis, the method comprising administering an effective dose of a strontium-containing compound (a) to the mammal. A method for the treatment and/or prophylaxis of an osteonecrotic bone disease, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis, glucocorticoid induced bone ischemia/osteonecrosis and femoral head necrosis, in a mammal who is to be or is treated with a therapeutic agent (b) known to or suspected of inducing apoptosis and/or necrosis of bone cells, the method comprising administering a strontium-containing compound (a) in combination with (b).
一种治疗和/或预防哺乳动物骨骼坏死性疾病的方法,例如特发性或继发性骨坏死、无血管性骨坏死、糖皮质激素诱导的骨缺血/骨坏死、莱格-卡尔韦-佩尔特斯病和股骨头坏死,该方法包括向哺乳动物投予含锶化合物(a)的有效剂量。一种治疗和/或预防骨骼坏死性疾病的方法,例如特发性或继发性骨坏死、无血管性骨坏死、糖皮质激素诱导的骨缺血/骨坏死和股骨头坏死,在将要或正在接受已知或疑似诱导骨细胞凋亡和/或坏死的治疗剂(b)的哺乳动物中,该方法包括给予含锶化合物(a)与(b)的组合。